Tiger Brokers

US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Definium Therapeutics

44.91
-0.4900-1.08%
Pre-market: 44.56-0.3500-0.78%08:35 EDT
Volume:1.36M
Turnover:61.41M
Market Cap:6.03B
PE:-12.90
High:46.57
Open:45.89
Low:44.81
Close:45.40
52wk High:49.70
52wk Low:8.70
Shares:134.37M
Float Shares:131.11M
Volume Ratio:0.72
T/O Rate:1.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4823
EPS(LYR):-2.0600
ROE:-64.09%
ROA:-20.64%
PB:6.57
PE(LYR):-21.80

Loading ...

OverviewCompanyNewsFilings

Definium Therapeutics Posts Strong Phase 3 GAD Data for DT120

TIPRANKS
·
Aug 19

Definium Therapeutics Issues Inducement Stock Options to New Hires

TIPRANKS
·
Aug 19

Definium Therapeutics Initiated at Buy by B of a Securities

Dow Jones
·
Aug 18

Definium Therapeutics initiated with a Buy at BofA

TIPRANKS
·
Aug 18

Definium Therapeutics Issues Inducement Stock Options for 32,900 Shares to New Hires

Reuters
·
Aug 18

Definium Therapeutics price target raised to $66 from $57 at RBC Capital

TIPRANKS
·
Aug 17

Definium Therapeutics Price Target Raised to $55.00/Share from $50.00 by Maxim Group

Dow Jones
·
Aug 15

Analysts Conflicted on These Healthcare Names: Definium Therapeutics (DFTX), Ionis Pharmaceuticals (IONS) and Sutro Biopharma (STRO)

TIPRANKS
·
Aug 15

Definium Therapeutics Publishes Corporate Presentation Outlining DT120 ODT Clinical Development Pipeline in Mental Health Indications

Reuters
·
Aug 14

Definium Therapeutics' DT120 Data Boosts Confidence in Future Trials, RBC Capital Markets Says

MT Newswires Live
·
Aug 13

RBC Adjusts PT on Definium Therapeutics to $66 From $57, Keeps Outperform Speculative Risk Rating

MT Newswires Live
·
Aug 13

U.S. Research Roundup-Airbnb, Five Below, Silgan Holdings

Reuters
·
Aug 13

Sector Update: Healthcare Stocks Advance Late Afternoon

MT Newswires Live
·
Aug 13

Definium Therapeutics Price Target Raised to $66.00/Share from $50.00 by Needham

Dow Jones
·
Aug 13

U.S. Stocks on the MOVE-Sutro Biopharma, Humacyte

Reuters
·
Aug 13

Top Midday Stories: Consumer Prices Rise 3.4% YoY in July; CoreWeave Q2 Loss Narrower Than Expectations

MT Newswires Live
·
Aug 12

Ami Fadia Reiterates Buy on Definium (DFTX) as Strong Phase 3 VOYAGE Data Support Unchanged $50 Price Target

TIPRANKS
·
Aug 12

Exchange-Traded Funds, Equity Futures Gain Pre-Bell Wednesday Amid In-Line Consumer Inflation Data, Tech Gains

MT Newswires Live
·
Aug 12

Definium Therapeutics Posts Phase 3 Voyage Topline Results Presentation

Reuters
·
Aug 12

Definium Therapeutics Shares Jump 22% Premarket After Co's Anxiety Disorder Drug Meets Late-Stage Trial Goal

THOMSON REUTERS
·
Aug 12
More